Oxidation of Therapeutic Proteins and Peptides: Structural and Biological Consequences

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pharmaceutical Research

• Publication date

  2013-09-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11095-013-1199-9PMID 24065593
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of oxidation sites and covalent cross-links in metal catalyzed oxidized interferon Beta-1a: potential implications for protein aggregation and immunogenicity.

  2013cited by this paper
• Triethylenetetramine prevents insulin aggregation and fragmentation during copper catalyzed oxidation.

  2013cited by this paper
• Metal-catalyzed oxidation of protein methionine residues in human parathyroid hormone (1-34): formation of homocysteine and a novel methionine-dependent hydrolysis reaction.

  2013cited by this paper
• Preclinical Models Used for Immunogenicity Prediction of Therapeutic Proteins

  2013cited by this paper
• Rates and impact of human antibody glycation in vivo.

  2012cited by this paper
• Chemical Modifications in Aggregates of Recombinant Human Insulin Induced by Metal-Catalyzed Oxidation: Covalent Cross-Linking via Michael Addition to Tyrosine Oxidation Products

  2012cited by this paper
• Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice

  2012cited by this paper
• Oxidation of human growth hormone by oxygen-centered radicals: formation of Leu-101 hydroperoxide and Tyr-103 oxidation products.

  2012cited by this paper
• Models for evaluation of relative immunogenic potential of protein particles in biopharmaceutical protein formulations.

  2012cited by this paper
• Polysorbates, peroxides, protein aggregation, and immuno- genicity - a growing concern.

  2012cited by this paper
• Hypoxia-Induced Oxidative Stress in Health Disorders

  2012cited by this paper
• Measuring Parathyroid Hormone (PTH) in Patients with Oxidative Stress – Do We Need a Fourth Generation Parathyroid Hormone Assay?

  2012cited by this paper
• Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin

  2012cited by this paper
• Identification of Potential Sites for Tryptophan Oxidation in Recombinant Antibodies Using tert-Butylhydroperoxide and Quantitative LC-MS

  2011cited by this paper
• Hypoxia. 1. Intracellular sensors for oxygen and oxidative stress: novel therapeutic targets.

  2011cited by this paper
• Plain and mono-pegylated recombinant human insulin exhibit similar stress-induced aggregation profiles.

  2011cited by this paper
• Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice

  2011cited by this paper
• A New Strategy to Stabilize Oxytocin in Aqueous Solutions: I. The Effects of Divalent Metal Ions and Citrate Buffer

  2011cited by this paper
• Reactive Impurities in Excipients: Profiling, Identification and Mitigation of Drug–Excipient Incompatibility

  2011cited by this paper
• Oxidized recombinant human growth hormone that maintains conformational integrity.

  2011cited by this paper
• Enhanced physical stability of human calcitonin after methionine oxidation.

  2011cited by this paper
• Bioactivity Determination of Native and Variant Forms of Therapeutic Interferons

  2011cited by this paper
• Chemical Modifications in Therapeutic Protein Aggregates Generated under Different Stress Conditions

  2011influential reference
• Stability of human growth hormone: influence of methionine oxidation on thermal folding.

  2011cited by this paper
• Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies.

  2011cited by this paper
• Classification and Characterization of Therapeutic Antibody Aggregates

  2011influential reference
• Structural and functional changes in human insulin induced by the lipid peroxidation byproducts 4-hydroxy-2-nonenal and 4-hydroxy-2-hexenal.

  2011influential reference
• Engineering of Therapeutic Proteins Production in Escherichia coli

  2011cited by this paper
• Oxidative Stress and Air Pollution Exposure

  2011cited by this paper
• Immunogenicity of Therapeutic Proteins: The Use of Animal Models

  2011cited by this paper
• Elution behavior of insulin on high-performance size exclusion chromatography at neutral pH.

  2010cited by this paper
• Chemical and functional changes of human insulin by in vitro incubation with blood from diabetic patients in oxidative stress.

  2010cited by this paper
• Oxidative modifications in glycated insulin

  2010cited by this paper
• Conformational changes in oxidatively stressed monoclonal antibodies studied by hydrogen exchange mass spectrometry

  2010cited by this paper
• Identification of methionine sulfoxide diastereomers in immunoglobulin gamma antibodies using methionine sulfoxide reductase enzymes

  2010cited by this paper
• Separation of post-translational modifications in monoclonal antibodies by exploiting subtle conformational changes under mildly acidic conditions.

  2010cited by this paper
• Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding*

  2010cited by this paper
• Protein oxidation during long storage: identification of the oxidation sites in dihydrofolate reductase from Escherichia coli through LC-MS and fragment studies.

  2009cited by this paper
• Mass spectrometry analysis of photo-induced methionine oxidation of a recombinant human monoclonal antibody

  2009cited by this paper
• Towards Heat-stable Oxytocin Formulations: Analysis of Degradation Kinetics and Identification of Degradation Products

  2009cited by this paper
• Methionine, tryptophan, and histidine oxidation in a model protein, PTH: mechanisms and stabilization.

  2009cited by this paper
• Human IgG1 Hinge Fragmentation as the Result of H2O2-mediated Radical Cleavage

  2009cited by this paper
• IgG2m4, an engineered antibody isotype with reduced Fc function

  2009cited by this paper
• Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors.

  2009cited by this paper
• Characterization of the photodegradation of a human IgG1 monoclonal antibody formulated as a high-concentration liquid dosage form.

  2009cited by this paper
• Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn

  2009cited by this paper
• Effect of methionine oxidation of a recombinant monoclonal antibody on the binding affinity to protein A and protein G.

  2008cited by this paper
• Oxidation of proteins: Basic principles and perspectives for blood proteomics

  2008cited by this paper
• Protein therapeutics: a summary and pharmacological classification

  2008cited by this paper
• Air pollution, oxidative stress and dietary supplementation: a review

  2008cited by this paper
• The effects of sucrose on stability of human brain natriuretic peptide [hBNP (1-32)] and human parathyroid hormone [hPTH (1-34)].

  2008cited by this paper
• Structural effect of deglycosylation and methionine oxidation on a recombinant monoclonal antibody.

  2008cited by this paper
• Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation.

  2008cited by this paper
• Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways.

  2008cited by this paper
• Effect of Copper Sulfate on Performance of a Serum‐Free CHO Cell Culture Process and the Level of Free Thiol in the Recombinant Antibody Expressed

  2008cited by this paper
• Identification of a single tryptophan residue as critical for binding activity in a humanized monoclonal antibody against respiratory syncytial virus.

  2007cited by this paper
• Recombinant protein therapeutics from CHO cells : 20 years and counting

  2007cited by this paper
• Protect from light: photodegradation and protein biologics.

  2007cited by this paper
• Selective oxidation of Zn2+ -insulin catalyzed by Cu2+.

  2007cited by this paper
• Isolation and characterization

  2006cited by this paper
• Structural and functional changes in human insulin induced by methylglyoxal

  2006cited by this paper
• Evaluation of recombinant human interferon alpha-2b structure and stability by in-gel tryptic digestion, H/D exchange and mass spectrometry.

  2006cited by this paper
• Posttranslational Oxidative Modifications of Proteins

  2006cited by this paper
• The oxidative environment and protein damage.

  2005cited by this paper
• Chapter 6 Structural characterization and immunogenicity in wildtype and immune tolerant mice of degraded recombinant human interferon alpha 2 b

  2005cited by this paper
• Oxidation by reactive oxygen species (ROS) alters the structure of human insulin and decreases the insulin-dependent D-glucose-C14 utilization by human adipose tissue.

  2005cited by this paper
• Aggregation of granulocyte‐colony stimulating factor in vitro involves a conformationally altered monomeric state

  2005cited by this paper
• Mass spectrometrical analysis of recombinant human growth hormone (Genotropin®) reveals amino acid substitutions in 2% of the expressed protein

  2005cited by this paper
• Effect of oxidative stress on the production of recombinant human interferon‐γ in Escherichia coli

  2005cited by this paper
• Early stages of salmon calcitonin aggregation: effect induced by ageing and oxidation processes in water and in the presence of model membranes.

  2005cited by this paper
• Structural Characterization and Immunogenicity in Wild-Type and Immune Tolerant Mice of Degraded Recombinant Human Interferon Alpha2b

  2005cited by this paper
• Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer’s Aβ peptides

  2004cited by this paper
• Polyethylene glycol-induced precipitation of interferon alpha-2a followed by vacuum drying: development of a novel process for obtaining a dry, stable powder.

  2004cited by this paper
• Moisture-Induced Aggregation of Lyophilized Insulin

  2004cited by this paper
• Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat.

  2003cited by this paper
• Effects induced by hydroxyl radicals on salmon calcitonin: a RP-HPLC, CD and TEM study.

  2003influential reference
• WATKINS JB 3RD. DIABETES, OXIDATIVE STRESS, AND ANTIOXIDANTS: A REVIEW

  2003cited by this paper
• Diabetes, oxidative stress, and antioxidants: A review

  2003cited by this paper
• Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans.

  2003cited by this paper
• High Sensitivity of Zn2+ Insulin to Metal-Catalyzed Oxidation: Detection of 2-Oxo-Histidine by Tandem Mass Spectrometry

  2002cited by this paper
• Immunoglobulin transport across polarized epithelial cells

  2002cited by this paper
• Stabilization of Pharmaceuticals to Oxidative Degradation

  2002cited by this paper
• Effect of dietary mannan oligosaccharides and(or) pharmacological additions of copper sulfate on growth performance and immunocompetence of weanling and growing/finishing pigs.

  2002cited by this paper
• Metal-catalyzed oxidation of human growth hormone: modulation by solvent-induced changes of protein conformation.

  2001cited by this paper
• The hydrogen peroxide/copper ion system, but not other metal-catalyzed oxidation systems, produces protein-bound dityrosine.

  2001cited by this paper
• Structural Analysis of Modified Forms of Recombinant IFN-β Produced under Stress-Simulating Conditions

  2000cited by this paper
• QUANTIFICATION AND SIGNIFICANCE OF PROTEIN OXIDATION IN BIOLOGICAL SAMPLES*

  2000cited by this paper
• Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.

  1999cited by this paper
• Chemical modification and site-directed mutagenesis of methionine residues in recombinant human granulocyte colony-stimulating factor: effect on stability and biological activity.

  1999cited by this paper
• Instability, stabilization, and formulation of liquid protein pharmaceuticals.

  1999cited by this paper
• Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).

  1998cited by this paper
• Oxidation of recombinant methionyl human granulocyte colony stimulating factor.

  1998cited by this paper
• Structural and Functional Differences Between Glycosylated and Non-glycosylated Forms of Human Interferon-β (IFN-β)

  1998cited by this paper
• Clinical investigation of the immunogenicity of interferon-alpha 2a.

  1997cited by this paper
• Standard conformations for the canonical structures of immunoglobulins.

  1997cited by this paper
• Metal-catalyzed photooxidation of histidine in human growth hormone.

  1997cited by this paper
• Degradation pathways of salmon calcitonin in aqueous solution.

  1997cited by this paper
• The crystal structure of human interferon beta at 2.2-A resolution.

  1997cited by this paper
• Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2.

  1997cited by this paper
• The crystal structure of human interferon beta at 2.2-A resolution.

  1997cited by this paper

• Impacts of methionine oxidation on product quality and anti-tumor activity of a therapeutic monoclonal antibody.

  2026cites this paper
• Recent advances in small molecules for amyloid fibril inhibition: chemical strategies and molecular mechanistic insights from lysozyme and insulin models.

  2026cites this paper
• Magnetic immunoprecipitation assay for the isolation of adalimumab and degradation products in preclinical biological samples.

  2026cites this paper
• Comprehensive forced degradation study revealing diverse chemical and physical degradation pathways of AAV8.

  2026cites this paper
• Near UV and Visible Light-Induced Degradation of IgG2: Photo-Fenton Reaction in Citrate Buffer.

  2026cites this paper
• A single point mutation on FLT3L-Fc protein increases the risk of immunogenicity

  2025cites this paper
• Plasminogen-cyclodextrin aerosol for ARDS: activity retention in simulated oxygen therapy and inflammation-triggered clot lysis.

  2025cites this paper
• Cataract‐Causing Mutant R188C of βB2 Crystallin With Low Structural Stability is Sensitive to Environmental Stresses and Prone to Aggregates Formation

  2025cites this paper
• Antibody Oxidation and Impact of Formulation: A High-Throughput Screening Approach.

  2025cites this paper
• Protein and Peptide Therapeutics: Stability Challenges, Regulatory Demands, and Innovative Formulation Solutions for Enhanced Clinical Effectiveness.

  2025cites this paper
• Photostability of Topoisomerase I Inhibitor Conjugated IgG1 Antibody-Drug Conjugates: Characterization Study and Degradation Mechanism Analysis.

  2025cites this paper
• Rational design of oxidation-resistant antibodies through local electrostatic modulation

  2025cites this paper
• Mechanistic insights into PS80 oxidative degradation in glass vials: Roles of critical factors (iron, histidine, aluminum, zinc) and their synergistic interactions.

  2025cites this paper
• MECHANISM OF LOW MOLECULAR WEIGHT IMPURITY FORMATION IN AN IgG1 MONOCLONAL ANTIBODY FORMULATION.

  2025cites this paper
• Impact of vial quality on interactions, particle formation, container closure integrity, and gas permeability for frozen drug product storage.

  2025cites this paper
• Toward Site-Specific Characterization of Structural Perturbations on Glycosylated Fc Using NMR at Natural Abundance

  2025cites this paper
• Microflow LC-MS/MS reveals platform-specific post-translational modification signatures in recombinant adeno-associated virus capsids linked to enhanced potency and stability: A quality control framework for gene therapy.

  2025cites this paper
• Recurrent Neural Networks Predict Future Peptide Aggregation for Drug Development.

  2025cites this paper
• Iminium catalysis in natural Diels–Alderase

  2025cites this paper
• Creating Glepaglutide, the First Long-Acting GLP-2 Analogue to Enable a Ready-to-Use Injection.

  2025cites this paper
• Regulatory Considerations in Synthetic Peptide Characterization: Techniques and Compliance

  2025cites this paper
• Expression of Enterocin A in Saccharomyces cerevisiae.

  2025cites this paper
• A novel chromatography method for high purity production of Recombinant human parathyroid hormone from E. coli

  2025cites this paper
• Utilization of Liquid Chromatography-Mass Spectrometry and High-Resolution Ion Mobility-Mass Spectrometry to Characterize Therapeutically Relevant Peptides with Asparagine Deamidation and Isoaspartate.

  2024cites this paper
• Considerations on the stability of IgG antibody in clinical specimens

  2024cites this paper
• Unveiling the Arsenal against Antibiotic Resistance: Antibacterial Peptides as Broad-Spectrum Weapons Targeting Multidrug-Resistant Bacteria

  2024cites this paper
• Perspectives for Photocatalytic Decomposition of Environmental Pollutants on Photoactive Particles of Soil Minerals

  2024cites this paper
• Stability of Protein Pharmaceuticals: Recent Advances

  2024cites this paper
• Insulin oxidation and oxidative modifications alter glucose uptake, cell metabolism, and inflammatory secretion profiles

  2024cites this paper
• The effect of glass container surface silanol density on monoclonal antibody formulation stability after application of mechanical shock.

  2024cites this paper
• Near UV and Visible Light-Induced Degradation of Bovine Serum Albumin and a Monoclonal Antibody Mediated by Citrate Buffer and Fe(III): Reduction vs Oxidation Pathways.

  2024cites this paper
• Decoding the Challenges: navigating Intact Peptide Mass Spectrometry-Based Analysis for Biological Applications

  2024cites this paper
• In-Depth Characterization for Methionine Oxidization in Complementary Domain Region by Hydrophobic Interaction Chromatography.

  2024cites this paper
• Development of a high throughput oxidation profiling strategy for monoclonal antibody products.

  2024cites this paper
• Comparative understanding of peroxide quantitation assays: a case study with peptide drug product degradation.

  2024cites this paper
• Optimized peptide nanofibrils as efficient transduction enhancers for in vitro and ex vivo gene transfer

  2023cites this paper
• Espectrometria de massas: uma ferramenta versátil para a caracterização de anticorpos monoclonais terapêuticos

  2023cites this paper
• The structure of model and peptide disulfides markedly affects their reactivity and products formed with singlet oxygen.

  2023cites this paper
• Oxidant-modified amylin fibrils and aggregates alter the inflammatory profile of multiple myeloid cell types, but are non-toxic to islet β cells

  2023cites this paper
• Characterization and Validation of a Middle-Down Hydrophobic Interaction Chromatography Method to Monitor Methionine Oxidation in IgG1

  2023cites this paper
• Association between serum apolipoprotein A1 and atrial fibrillation in the Chinese population: a case–control study

  2023cites this paper
• Comprehensive characterization of higher order structure changes in methionine oxidized monoclonal antibodies via NMR chemometric analysis and biophysical approaches

  2023cites this paper
• Oxime blot: A novel method for reliable and sensitive detection of carbonylated proteins in diverse biological systems

  2023cites this paper
• Correlated analytical and functional evaluation of higher order structure perturbations from oxidation of NISTmAb

  2023cites this paper
• QUALITY EVALUATION OF PHARMACEUTICAL HUMAN SERUM ALBUMIN PREPARATIONS AVAILABLE IN PHARMACIES IN ADEN GOVERNORATE - YEMEN

  2023cites this paper
• Solidification and Oral Delivery of Biologics to the Colon- A Review.

  2023cites this paper
• Development of a Rapid Adeno-Associated Virus (AAV) Identity Testing Platform through Comprehensive Intact Mass Analysis of Full-Length AAV Capsid Proteins

  2023cites this paper
• In silico prediction of post-translational modifications in therapeutic antibodies

  2022cites this paper
• Stress Factors in Primary Packaging, Transportation and Handling of Protein Drug Products and Their Impact on Product Quality.

  2022cites this paper
• Promising Role of Silk-Based Biomaterials for Ocular-Based Drug Delivery and Tissue Engineering

  2022cites this paper
• Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates

  2022cites this paper
• Nucleation in protein aggregation in biotherapeutic development: a look into the heart of the event.

  2022cites this paper
• Instability Challenges and Stabilization Strategies of Pharmaceutical Proteins

  2022cites this paper
• A review of methods to increase the stability of recombinant pharmaceutical proteins during the production and storage process

  2022cites this paper
• Synthetic pharmaceutical peptides characterization by chromatography principles and method development.

  2022cites this paper
• Physicochemical and biological impact of metal-catalyzed oxidation of IgG1 monoclonal antibodies and antibody-drug conjugates via reactive oxygen species

  2022cites this paper
• Investigation of immune responses to oxidation, deamidation, and isomerization in therapeutic antibodies using preclinical immunogenicity risk assessment assays.

  2022cites this paper
• Oxidative modifications control aberrant tyrosine kinase activity.

  2022cites this paper
• A Reactive Oxygen Species-Scavenging ‘Stealth’ Polymer, Poly(thioglycidyl glycerol), Outperforms Poly(ethylene glycol) in Protein Conjugates and Nanocarriers and Enhances Protein Stability to Environmental and Biological Stressors

  2022cites this paper
• Denaturing and Native Mass Spectrometric Analytics for Biotherapeutic Drug Discovery Research: Historical, Current, and Future Personal Perspectives.

  2021cites this paper
• Natural Polysaccharides as Preventive and Therapeutic Horizon for Neurodegenerative Diseases

  2021cites this paper
• High-Resolution Ion-Mobility-Enabled Peptide Mapping for High-Throughput Critical Quality Attribute Monitoring.

  2021cites this paper
• Argireline: Needle‐Free Botox as Analytical Challenge

  2021cites this paper
• Machine learning prediction of methionine and tryptophan photooxidation susceptibility

  2021cites this paper
• Detection of LongR3 -IGF-I, Des(1-3)-IGF-I, and R3 -IGF-I using immunopurification and high resolution mass spectrometry for anti-doping purposes.

  2021cites this paper
• Oxidation and Deamidation of Monoclonal Antibody Products: Potential Impact on Stability, Biological Activity, and Efficacy.

  2021cites this paper
• Minimizing Oxidation of Freeze-Dried Monoclonal Antibodies in Polymeric Vials Using a Smart Packaging Approach

  2021cites this paper
• Site-specific Conjugation of a Selenopolypeptide to Alpha-1-antitrypsin Enhances Oxidation Resistance and Pharmacological Properties.

  2021cites this paper
• Analysis of N15-rat growth hormone after incubation with rat subcutaneous tissue and immune cells using ultra-pressure chromatography-mass spectrometry.

  2021cites this paper
• Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods.

  2021cites this paper
• Current status and future prospects for ion-mobility mass spectrometry in the biopharmaceutical industry.

  2021cites this paper
• Chemical-gas sterilization of external surface of polymer-based prefilled syringes and its effect on stability of model therapeutic protein.

  2021cites this paper
• Aggregation of protein therapeutics enhances their immunogenicity: causes and mitigation strategies

  2021cites this paper
• Stress Factors in Protein Drug Product Manufacturing and Their Impact on Product Quality.

  2021cites this paper
• Investigating Photodegradation of Antibodies Governed by the Light Dosage.

  2021cites this paper
• Modulation of Amyloid Protein Fibrillation by Synthetic Polymers: Recent Advances in the Context of Neurodegenerative Diseases.

  2020cites this paper
• Modulation of granulocyte colony stimulating factor conformation and receptor binding by methionine oxidation

  2020cites this paper
• Tryptophan Oxidation of a Monoclonal Antibody Under Diverse Oxidative Stress Conditions: Distinct Oxidative Pathways Favor Specific Tryptophan Residues.

  2020cites this paper
• Identification and Quantification of Oxidation Products in Full-Length Biotherapeutic Antibodies by NMR Spectroscopy

  2020cites this paper
• Pivotal Biology, Chemistry, Biochemistry, and Biophysical Concepts of Biologics and Biosimilars

  2020cites this paper
• Developability in biophysical characterization

  2020cites this paper
• Oxidation of protein disulfide bonds by singlet oxygen gives rise to glutathionylated proteins

  2020cites this paper
• Carbon radicals generated by solid polymers: Electron spin resonance spectroscopy for detection of species in water

  2020cites this paper
• Assessing the range of enzymatic and oxidative tunability for biosensor design.

  2020cites this paper
• Non-invasive strategies for protein drug delivery: Oral, transdermal, and pulmonary

  2020cites this paper
• Understanding Oxidation Propensity in GCSF and Assessment of its Safety and Efficacy

  2020cites this paper
• Modulation of GCSF Conformation and Receptor Binding by Methionine Oxidation.

  2020cites this paper
• Proteolysis and oxidation of therapeutic proteins after intradermal or subcutaneous administration.

  2020cites this paper
• Protein Sub-Visible Particle and Free Radical formation of a Freeze-Dried Monoclonal Antibody Formulation during Dropping.

  2020cites this paper
• The ELISA Detectability and Potency of Pegfilgrastim Decrease in Physiological Conditions: Key Roles for Aggregation and Individual Variability

  2020cites this paper
• Controlled Polysorbate 20 Hydrolysis - A new Approach to Assess the Impact of Polysorbate 20 Degradation on Biopharmaceutical Product Quality in Shortened Time.

  2020cites this paper
• Protein NMR of biologicals: analytical support for development and marketed products

  2020cites this paper
• Protein Formulations Containing Polysorbates: Are Metal Chelators Needed at All?

  2020cites this paper
• Determining the Sources of Variance in the Preparation of Analytical Standards for Chromatographic Analysis of a Lyophilized Peptide Drug Substance by Nested ANOVA Statistical Analysis

  2020cites this paper
• Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!

  2020cites this paper
• Development of Biopharmaceutical Drug-Device Products

  2020influential citation
• Chapter 9: Leveraging the Multi-attribute Method (MAM) to Improve Biotherapeutic Development

  2020cites this paper
• Reply

  2020cites this paper
• Impact of mAb Aggregation on its Biological Activity: Rituximab as a Case Study.

  2020cites this paper
• Formation of Protein Sub-Visible Particles during Powder Grinding of a Monoclonal Antibody.

  2020cites this paper